Carl Jonas Stefan Ståhlberg
Comptroller/Controller/Auditor chez NovaSAID AB
Profil
Carl Jonas Stefan Ståhlberg is currently working as a Chief Auditor in five different companies, namely Almi Stockholm Investeringsfond AB, Akinion Pharmaceuticals AB, NovaSAID AB, Almi Invest Stockholm AB, and Vectura Fastigheter AB.
He previously worked as a Chief Auditor at ClanoTech AB.
Postes actifs de Carl Jonas Stefan Ståhlberg
| Sociétés | Poste | Début |
|---|---|---|
NovaSAID AB
 NovaSAID AB Pharmaceuticals: MajorHealth Technology NovaSAID AB develops treatments for inflammation and pain in conditions such as rheumatoid arthritis. It discovers selective microsomal prostaglandin E synthase-1 (mPGES-1), and has also demonstrated its effect in animal models for pain and inflammation. The firm's approach is to prevent the pathological formation of prostaglandin E2 (PGE2) selectively, through the development of inhibitors of mPGES-1, the enzyme that is responsible for the formation of PGE2 during inflammation. Its mPGES-1 inhibition offers an approach for inhibiting pathological PGE2 production without adversely affecting other important prostanoids. The company was founded by Per-Johan Göte Jakobsson, Ralf Morgenstern, Bertil Samuelsson and Bengt Ingemar Samuelsson on October 26, 2004 and is headquartered in Solna, Sweden. | Comptroller/Controller/Auditor | - |
Akinion Pharmaceuticals AB
 Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Akinion Pharmaceuticals AB operates as a holding company that focuses on the development of pharmaceutical for the treatment of acute myeloid leukemia. It develops, markets, and sells a product based on Biovitrum’s anti leukemia kinase inhibitor research. It is a drug development that manufactures a lead candidate drug, AKN-028, which is a small molecule kinase inhibitor. The company was founded by Vendela Parrow in 2009 and is headquartered in Solna, Sweden. | Comptroller/Controller/Auditor | - |
Almi Stockholm Investeringsfond AB
 Almi Stockholm Investeringsfond AB Finance/Rental/LeasingFinance Almi Stockholm Investeringsfond AB provides financing to small businesses in the early stages. It also offers financial advice to businesses. The company was founded on January 23, 1980 and is headquartered in Stockholm, Sweden. | Comptroller/Controller/Auditor | - |
Vectura Fastigheter AB
 Vectura Fastigheter AB Real Estate DevelopmentFinance Vectura Fastigheter AB owns and manages real estate. Its properties consist of community services, hotels, and offices. The company was founded in 2012 and is headquartered in Stockholm, Sweden. | Comptroller/Controller/Auditor | - |
Almi Invest Stockholm AB
 Almi Invest Stockholm AB Finance/Rental/LeasingFinance Almi Invest Stockholm AB operates as a venture capital firms. It provides risk capital. The firm specializes in venture capital investments. The company was founded on September 3, 2008 and is headquartered in Stockholm, Sweden. | Comptroller/Controller/Auditor | - |
Anciens postes connus de Carl Jonas Stefan Ståhlberg
| Sociétés | Poste | Fin |
|---|---|---|
ClanoTech AB
 ClanoTech AB Pharmaceuticals: MajorHealth Technology ClanoTech AB is a holding company that develops drugs for the treatment of cancer and macular degeneration. Its lead candidate is an inhibitor of the alpha5beta1-integrin receptor which is present in fibroblast and on vascular endothelial cells. Its Alpha5beta1-integrin is strongly up-regulated in fibroblast when switching to the fibrotic state and in scars after glaucoma surgery. Its strategy spans from therapeutic areas with high commercial potential as wet Age Regulated Macular Degeneration to ophthalmology niche indications with orphan drug opportunity such as developing advent in glaucoma surgery techniques. The company was founded by Yihai Cao in 2006 and is headquartered in Solna, Sweden. | Comptroller/Controller/Auditor | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
NovaSAID AB
NovaSAID AB Pharmaceuticals: MajorHealth Technology NovaSAID AB develops treatments for inflammation and pain in conditions such as rheumatoid arthritis. It discovers selective microsomal prostaglandin E synthase-1 (mPGES-1), and has also demonstrated its effect in animal models for pain and inflammation. The firm's approach is to prevent the pathological formation of prostaglandin E2 (PGE2) selectively, through the development of inhibitors of mPGES-1, the enzyme that is responsible for the formation of PGE2 during inflammation. Its mPGES-1 inhibition offers an approach for inhibiting pathological PGE2 production without adversely affecting other important prostanoids. The company was founded by Per-Johan Göte Jakobsson, Ralf Morgenstern, Bertil Samuelsson and Bengt Ingemar Samuelsson on October 26, 2004 and is headquartered in Solna, Sweden. | Health Technology |
Akinion Pharmaceuticals AB
Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Akinion Pharmaceuticals AB operates as a holding company that focuses on the development of pharmaceutical for the treatment of acute myeloid leukemia. It develops, markets, and sells a product based on Biovitrum’s anti leukemia kinase inhibitor research. It is a drug development that manufactures a lead candidate drug, AKN-028, which is a small molecule kinase inhibitor. The company was founded by Vendela Parrow in 2009 and is headquartered in Solna, Sweden. | Health Technology |
ClanoTech AB
ClanoTech AB Pharmaceuticals: MajorHealth Technology ClanoTech AB is a holding company that develops drugs for the treatment of cancer and macular degeneration. Its lead candidate is an inhibitor of the alpha5beta1-integrin receptor which is present in fibroblast and on vascular endothelial cells. Its Alpha5beta1-integrin is strongly up-regulated in fibroblast when switching to the fibrotic state and in scars after glaucoma surgery. Its strategy spans from therapeutic areas with high commercial potential as wet Age Regulated Macular Degeneration to ophthalmology niche indications with orphan drug opportunity such as developing advent in glaucoma surgery techniques. The company was founded by Yihai Cao in 2006 and is headquartered in Solna, Sweden. | Health Technology |
Almi Stockholm Investeringsfond AB
Almi Stockholm Investeringsfond AB Finance/Rental/LeasingFinance Almi Stockholm Investeringsfond AB provides financing to small businesses in the early stages. It also offers financial advice to businesses. The company was founded on January 23, 1980 and is headquartered in Stockholm, Sweden. | Finance |
Vectura Fastigheter AB
Vectura Fastigheter AB Real Estate DevelopmentFinance Vectura Fastigheter AB owns and manages real estate. Its properties consist of community services, hotels, and offices. The company was founded in 2012 and is headquartered in Stockholm, Sweden. | Finance |
Almi Invest Stockholm AB
Almi Invest Stockholm AB Finance/Rental/LeasingFinance Almi Invest Stockholm AB operates as a venture capital firms. It provides risk capital. The firm specializes in venture capital investments. The company was founded on September 3, 2008 and is headquartered in Stockholm, Sweden. | Finance |